Log In
Print
BCIQ
Print
Print this Print this
 

TK (HSV-TK) (formerly TBI-0301)

  Manage Alerts
Collapse Summary General Information
Company MolMed S.p.A.
DescriptionDonor lymphocytes engineered to express human herpes simplex thymidine kinase suicide gene
Molecular Target
Mechanism of ActionCell therapy
Latest Stage of DevelopmentPhase III
IndicationLeukemia
Partner

Takara Bio Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today